Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : Lapaquistat
CAS No.: 189060-13-7
Catalog No.: PC-61039Not For Human Use, Lab Use Only.
Lapaquistat (TAK-475) is a novel potent, competitive, orally active squalene synthase inhibitor with IC50 of 78 nM.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 1 mg | $138 | In stock | |
| 5 mg | $298 | In stock | |
| 10 mg | $488 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Lapaquistat (TAK-475) is a novel potent, competitive, orally active squalene synthase inhibitor with IC50 of 78 nM.
Lapaquistat (TAK-475) displays no effect on plasma aspartate aminotransferase and alanine aminotransferase activities.
Lapaquistat (TAK-475) effectively inhibits cholesterol synthesis in rat liver with ED50 of 2.9 mg/kg (p.o.), lowers plasma total cholesterol, triglyceride and phospholipid levels in rabbits, also inhibits the secretion of cholesterol, triglyceride and phospholipid components of very-low-density lipoprotein (VLDL) from liver.
| M.Wt | 645.146 | |
| Formula | C33H41ClN2O9 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
1-{2-[(3R,5S)-1-(3-acetoxy-2,2-dimethylpropyl)-7-chloro-1,2,3,5-tetrahydro-2-oxo-5-(2,3-dimethoxyphenyl)-4,1-benzoxazepine-3-yl] acetyl} piperidin-4-acetic acid |
|
1. Miki T, et al. J Med Chem. 2002 Sep 26;45(20):4571-80.
2. Amano Y, et al. Eur J Pharmacol. 2003 Apr 11;466(1-2):155-61.
3. Nishimoto T, et al. Br J Pharmacol. 2003 Jul;139(5):911-8.
4. Burnett JR. Curr Opin Investig Drugs. 2006 Sep;7(9):850-6.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
